Lanean...
Low-dose rituximab protocol in rheumatoid arthritis—outcome and economic impact
OBJECTIVES: A significant proportion of RA patients, particularly those associated with poor prognostic factors, fail on conventional DMARDs (cDMARDs). Although rituximab (RTX) has been effective in these patients, the cost of therapy makes it unaffordable, particularly in poor and developing countr...
Gorde:
| Argitaratua izan da: | Rheumatol Adv Pract |
|---|---|
| Egile Nagusiak: | , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Oxford University Press
2021
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7878847/ https://ncbi.nlm.nih.gov/pubmed/33605940 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/rap/rkaa077 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|